Current status of laparoscopic and robot-assisted nerve-sparing radical cystectomy in male patients  by Huang, Jian et al.
Asian Journal of Urology (2016) 3, 150e155Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier.com/locate/ajurREVIEWCurrent status of laparoscopic and robot-
assisted nerve-sparing radical cystectomy in
male patients
Jian Huang*, Xinxiang Fan, Wen DongDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaReceived 5 April 2016; received in revised form 28 April 2016; accepted 28 April 2016
Available online 27 May 2016KEYWORDS
Nerve-sparing;
Radical cystectomy;
Laparoscopy;
Robot-assisted
laparoscopy;
Male* Corresponding author.
E-mail address: urolhj@sina.com (
Peer review under responsibility
University.
http://dx.doi.org/10.1016/j.ajur.2016
2214-3882/ª 2016 Editorial Office of
under the CC BY-NC-ND license (http:Abstract During radical cystectomy (RC), the neurovascular bundles are easily removed or
damaged, leading to varying rates of incontinence and erectile dysfunction. The nerve-
sparing technique was developed to preserve urinary and erectile function. The adoption of
laparoscopic and robot-assisted technology has improved visualization and dexterity of pelvic
surgeries, thus facilitate the nerve-sparing technique. Although nerve-sparing RC is technically
similar with nerve-sparing radical prostatectomy, there are still some anatomical differences.
There are mainly three different types of nerve-sparing techniques. Pelvic lymph node dissec-
tion (PLND) is another important factor to influence erectile function and urinary continence.
Nerve-sparing laparoscopic radical cystectomy (LRC) and robot-assisted radical cystectomy
(RARC) may be an optimal treatment choice in well-selected younger patients with low-
volume, organ-confined disease. We should attempt to do, whenever possible, a nerve-sparing
cystectomy at least on oneside. However, due to the need of a well-refined surgical technique,
nerve-sparing LRC and RARC is now being performed only by experienced urological surgeons.
ª 2016 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).J. Huang).
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Radical cystectomy (RC) with neobladder reconstruction still
represents the first choice of treatment for both muscle-
invasive and high-risk non-muscle invasive bladder cancer. In
recent years, minimally invasive surgery such as laparoscopic
radical cystectomy (LRC) and robot-assisted radical cys-
tectomy (RARC) are performed more commonly at many
centerswith the technological advancements. The safety andion and hosting by Elsevier B.V. Ltd. This is an open access article
by-nc-nd/4.0/).
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quirements, improvedcosmesisandquick recoveryofLRCand
RARC compared to open RC (ORC) have been well established
[1e3]. At present, the ultimate goal of LRC and RARC is to
remove the tumor completely while still maintaining erectile
function and urinary continence at the same time.
During RC, particularly ORC, the neurovascular bundles
are easily removed or damaged. Varying rates of continence
and erectile function have been described after RC in the
literatures as the degree of injury to the neurovascular
bundles differed from technique to technique [4e6]. RC
was then modified on the basis of this information to avoid
injury to the neurovascular bundles and thus better pre-
serve erectile function and urinary continence in patients
undergoing this operation.
Although nerve-sparing RC has been proposed in the
1980s, progress of this procedure actually remained limited
over the years [7]. However, nerve-sparing radical prosta-
tectomy (RP),which iswidely applied formore than 20 years,
has achieved a consolidate position in routine clinical prac-
tice of every urologic unit [8]. Whether the nerve-sparing
technique in prostatectomy could be applied in RC is still
controversial. Firstly, the innervations of the neobladder
after RC is different from original bladder after RP. Secondly,
the voiding pressure of neobladder is much lower than orig-
inal bladder as the former does not have detrusor muscle. In
addition, the pelvic lymph node dissection (PLND) is much
more extensive during RC than RP, thus higher branches of
pelvic plexus may be injured. Moreover, as urothelial carci-
noma is considered to be a potential lethal disease, nerve-
sparing surgery may compromise the oncological safety.
Nevertheless, the adoption of laparoscopic and robot-
assisted technology has improved visualization and dex-
terity of pelvic surgeries. Several studies with varying re-
sults after nerve-sparing LRC have been published [8e10].
Herein we review the current available literatures con-
cerning the anatomic basis, nerve-sparing techniques, and
therapeutic effects of nerve-sparing LRC and RARC in male
patients. We aim to clarify the rational nerve-sparing
techniques and establish the proper patient selection
criteria.
2. Evidence acquisition
A literature search was performed in February 2016, using
the PubMed and the Web of Science databases. The
following terms and their combinations were searched in
Title/Abstract: “nerve-sparing”, “laparoscopic”, “robot-
assisted”, “radical cystectomy” and “male”. Case reports
and non-English articles were excluded. Full text case
series and their references were reviewed.
3. Evidence synthesis
3.1. New insights of the anatomical basis of nerve-
sparing radical cystectomy
In 1982, Walsh and Donker [11] suggested that erectile
dysfunction (ED) was caused by damage to the neurovascular
bundles (NVB), which supply the corpora cavernosa. In 1983,Walsh et al. [12] found that the branches of pelvic nerve
plexus which dominate corpora cavernosa locate laterally of
the prostate capsule and Denonvillier’s fascia. They spread
along the post lateral part of the prostate and the urethra,
the anteriorwall of the rectum.Thesedelicate nerves spread
along with the blood vessels supplying prostate, seminal
vesicle, bladder neck and urethra, and together they form
the NVBs which are embedded in the dense fibrous connec-
tive fat tissue [12]. NVBs play an important role in erectile
function and urinary control. By using cadaver models,
Costello et al. [13] further detailed the precise anatomy of
the NVBs because of their close relationship to the prostate
and seminal vesicles. They identified three functional com-
ponents of the NVBs. The first posterior and posterolateral
component runs within Denonvillier’s fascia and the para-
rectal fascia and innervates the rectum. The second lateral
component supplies the levator ani. The third component
cavernosal nerves and prostatic neurovascular supply, orig-
inally described by Walsh and colleagues [11,12], lie along
the posterolateral surface.
Takenaka et al. [14] confirmed that branches of the
hypogastric nerve and the pelvic splanchnic nerve are likely
to interdigitate at multiple levels, showing spray-like
arrangement without clear bundle formation. In addition,
Lunacek et al. [15] demonstrated that during the growth of
the prostate, the cavernous nerves running along the
prostate are displaced more anteriorly and spread, thus
forming a concave shape (like a “curtain”) of the NVBs.
Therefore, dissection of the NVBs has to start anteriorly to
preserve all the nerve fibers that are spread along the
surface of the lateral lobes of the prostate.
Although nerve-sparing RC is technically similar with
nerve-sparing RP, there are still some anatomical differ-
ences. During RC, the lateral portion of each bladder
vascular pedicle is stapled with a vascular staple load, and
a second staple load is used to divide the proximal portion
of the posterior pedicle. Clips and athermal dissection are
used to divide the distal portion of the posterior pedicle,
staying close to the seminal vesicles, thereby avoiding
undue damage to the erectile nerves that are in close
proximity lateral to the seminal vesicles [9,16]. In addition,
a more extended PLND should be performed in RC
compared with RP, and the erectile nerves are at risk of
injury when the lymph nodes in the presacral and internal
iliac area are being removed [17].
3.2. Different techniques of nerve-sparing radical
cystectomy
There are mainly three different types of nerve-sparing
techniques. Their main features and relative reports are
described below (Table 1).
3.2.1. Nerve-sparing cysto-vesicle prostatectomy (NS-
CVP)
This technique, adopted according to that initially
described by Schlegel and Walsh [18] in 1987, includes the
“en bloc” removal of bladder, prostate and seminal vesicles
only leaving the NVBs intact. This is the most commonly
used nerve-sparing procedure which was mainly carried
out by a transperitoneal approach, using a combined ante-
Table 1 Functional outcomes of different techniques of nerve-sparing radical cystectomy.
Study Technique Patients Follow-up Urinary continence Recovery of erectile
functionDaytime Night time
Kessler et al.,
2004 [5]
NS-CVP Bilateral:
n Z 38
Unilateral:
n Z 218
Non: n Z 75
24 months Attempted NS:
96%
Non NS: 88%
Attempted NS: 88%
Non NS: 74%
Bilateral: about 58%
Unilateral: about 32%
Non: about 12%
Colombo et al.,
2015 [8]
NS-CVP 35 24 months 88.6% 57.1% Satisfactory erectile
function rate
(IIEF-5  22)
28.6%
CS-S 36 97.2% 83.3% 91.6%
SS-CP 19 94.7% 63.2% 84.2%
Canda et al.,
2012 [19]
NS-CVP Bilateral:
n Z 19
Unilateral:
n Z 1
Non: n Z 1
About 6 months 11 (73.3%) fully
continent, 4
(26.6%) mild
incontinencea
3 (20%) good,
4 (26.7%) fair
and 8 (53.3%) poora
e
Jacobs et al.,
2015 [21]
NS-CVP 20 37 months At 12 months,
average urinary
function compared
with baseline
decreased by
13  30 points
Average sexual
function at 12 months,
decreased by 23  30
points
CS-C 20 41 months Decreased by
28  33 points
Decreased by 1  11
points
Ong et al., 2010
[23]
SS-CP Bilateral:
n Z 14
Unilateral:
n Z 17
18 months 27 out of 29
evaluable patients
(93%)
19 out of 29
evaluable
patients (66%)
15 out of 19 evaluable
patients (79%)
remained potent
NS-CVP, nerve-sparing cysto-vesicle prostatectomy, CS-S, capsule-sparing cystectomy, SS-CP, seminal-sparing cysto-prostatectomy;
IIEF, International index of erectile function.
a Only 15 patients were available for postoperative urinary continence evaluation.
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fascial prostatectomy [8].
Kessler et al. [5] assessed factors influencing urinary
continence and erectile function after RC and ileal ortho-
topic bladder substitution in 381 consecutive male patients.
These patients were classified into three groups, without
attempted nerve-sparing (n Z 75), attempted bilateral
nerve-sparing (n Z 38) and attempted unilateral nerve-
sparing (n Z 218). After 2 years of follow-up, 58% pa-
tients in bilateral nerve-sparing group could achieve re-
covery of erectile function, 32% in unilateral nerve-sparing
group, whereas only 12% in without attempted nerve-
sparing group. This study also demonstrated that attemp-
ted nerve sparing and age younger than 65 years are asso-
ciated with improved urinary continence [5]. Another study
by Colombo et al. [8] reported 35 patients underwent NS-
CVP, and their functional outcomes showed that 88.6% pa-
tients could achieve complete daytime urinary continence,
and 28.6% patients could achieve satisfactory erectile
function at 24 months after surgery. Canda et al. [19] re-
ported 21 male patients underwent robot-assisted nerve-
sparing RC with bilateral PLND and intracorporeal urinary
diversion for BCa, 15 were available for postoperative uri-
nary continence evaluation (four died and two were lost to
follow-up). Among those, 11 (73.3%) were fully continent
and four (26.6%) had mild urinary incontinence during thedaytime. Therefore, daytime urinary continence seems to
be very promising in male patients, although the follow-up
is currently very limited in this study. On the other hand,
for nighttime continence outcomes, three (20%) had good,
four (26.7%) had fair and eight (53.3%) had poor UI. Patients
with preoperative erectile function (IIEF score >7, nZ 11)
were instructed to use oral phosphodiesterase type 5 (PDE-
5) inhibitors after removal of the urethral catheter post-
operatively. However, only one patient used an oral PDE-5
inhibitor and clearly benefited from its use. Most of the
present patients had a decreased libido postoperatively.
Additionally, the follow-up is limited; therefore it is not
easy to comment on postoperative erectile functional
outcomes. The authors suggested that in longer term
follow-up increased use of PDE-5 inhibitors and an increase
in libido will result in better functional outcomes reflected
by increased IIEF scores [19].
3.2.2. Capsule-sparing cystectomy (CS-C)
This technique, described by Colombo et al. in 2001 [20],
includes a preliminary transurethral resection of prostate
(TURP) and then entire removal of the bladder while leav-
ing the prostate capsule, vas deferens, seminal vesicles and
NVBs intact. Biopsies of bladder neck and prostatic urethra
were obtained at the time of previous transurethral
resection of bladder tumors. TURP is carried out together
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exclude prostate cancer [8].
Colombo et al. [8] reported 36 patients underwent CS-C,
and their function outcomes showed that 97.2% patients
could achieve complete daytime urinary continence, and
91.6% patients could achieve satisfactory erectile function
at 24 months after surgery. Another randomized controlled
trial by Jacobs et al. [21] compared CS-C vs. NS-CVP, with
20 patients in each cohort. Neither sexual function nor
urinary continence could achieve significant differences
between the two groups.
3.2.3. Seminal-sparing cysto-prostatectomy (SS-CP)
This procedure was firstly described by Puppo et al. [22]
in 2008 and subsequently by Ong et al. [23] and Haut-
mann et al. [4] in 2010. The main steps include a blunt
extraperitoneal antegrade dissection between the poste-
rior bladder wall and the seminal vesicles up to the ejac-
ulatory ducts and a retrograde intrafascial prostatectomy.
With this procedure, seminal vesicles, vas deferens and
NVBs were left intact into the pelvis.
Colombo et al. [8] reported 19 patients underwent SS-CP,
and their functional outcomes showed that 94.7% patients
could achieve complete daytime urinary continence, and
84.2%patients could achieve satisfactory erectile function at
24 months after surgery. Ong et al. [23] reported 31 patients
(17 unilateral and 14 bilateral) underwent SS-CP. At last
follow-up (median 18 months), 27 out of 29 evaluable pa-
tients (93%) had daytime continence and 19 out of 29 (66%)
had nighttime continence. In terms of postoperative po-
tency, 15 out of 19 evaluable patients (79%) remained
potent. Hautmann et al. [4] reported nine patients under-
went SS-CP, and four out of nine patients maintained spon-
taneous complete tumescence, and five patients had partial
tumescence using sildenafil as a successful erectogenic aid.
3.3. The influence of PLND on erectile function and
urinary continence
In themale, the inferior hypogastric plexus, or pelvic plexus,
is responsible for the mechanisms of erection, ejaculation,
and urinary continence [17]. The pelvic plexus lies within a
fibrofatty, flat, rectangular, sagittally oriented plate be-
tween the bladder and the rectum [13]. PLND might be
extended into this area. So, PLND is another important factor
to influence erectile function and urinary continence. The
pelvic plexus and particularly the erectile nerves are at risk
of injury in a standard PLND during the medial dissection in
the area of the internal iliac area and towards the bladder
wall. A more extended PLND may damage branches of the
pelvic plexus providing the cavernous nerves which
contribute to erectile function. During extended PLND, the
nerves are also at risk of injury at their origin in the presacral
area and medial to the common iliac vessels [17]. In fact,
significantly better recovery of erectile function was re-
ported in men with negative lymph nodes compared to those
with positive lymph nodes [5].
Studies have shown that extended PLND provides addi-
tional survival benefits for patients with pT3-4 disease, but
not for patients with pT2 disease [24]. In addition, super
extended template up to the inferior mesenteric artery dosenot provide survival benefit compared with extended PLND
[25]. Nerve-sparing RC is usually restricted to cT2 patients,
for whom standard PLND is enough. So para-aortic lymph
nodes and presacral lymph nodes should not be removed
during nerve-sparing RC, unless there is suspected lymphatic
metastasis or palpable lymph nodes during surgery.
3.4. Surgical skills for nerve-sparing radical
cystectomy
Many of the NVBs fibers are microscopic and cannot be iden-
tifiedduring surgery.Thosenervesare locatedpostero-lateral
to the seminal vesicles and very close to their tips. Gentle
dissection of the seminal vesicles during RC may reduce the
risk of injury to these nerves and, in consequence, may
improve postoperative potency rates [26]. A high intrafascial
release of the NVB is performed with a strict athermal tech-
nique using Hem-o-Lok clips andmetal clips for hemostasis. It
is important to not accidentally transect the NVBs during
dissection close to the vesicles and the base of the prostate,
where the dissection is in close proximity to the NVBs [16].
In addition to a nerve sparing technique, the manage-
ment of the urethral sphincter mechanism at surgery is of
utmost importance. The less damage done to tissue related
to the sphincteric mechanism, the more likely patients will
be continent. For rapid achievement of continence after
surgery, the urethral supporting structures and a maximum
of membranous urethral length should be preserved [5].
3.5. Surgical indications for nerve-sparing radical
cystectomy
According to the above considerations, the nerve-sparing
technique is important for both preservation of sexual
function and urinary continence. Men with good erectile
function and preferring to preserve their potency after RC
may be candidates for preservation of NVBs. However,
nerve-sparing RC requires dissection close to the bladder,
exposing patients to the risks of positive surgical margins,
which may compromise tumor control. Thus, patient se-
lection is critically important when performing nerve-
sparing cystectomy. The risks and benefits of nerve
sparing should be assessed according to preoperative sexual
function and disease burden.
Firstly, age plays a significant role in the recovery of
erectile function after RC. Schoenberg et al. [27] demon-
strated that the overall potency of their cohort was 47%.
After brokendownbydecades,men in their 40s, 50s, 60s, and
70s had potency rates of 62%, 47%, 43%, and 20%, respec-
tively. Kessler et al. [5] also showed significantly better ef-
fects of the open nerve-sparing approach on men younger
than 65 years compared with those who were older. Patient
with a younger age may achieve better outcomes in term of
sexual function. In addition, the clinical tumor stage should
be restricted within T2 without evidence of disease at
bladder neck and a negative urethral margin at the time of
surgery is mandatory. Thirdly, we should exclude patients
probably with prostate cancer. Prostate specific antigen
(PSA) < 4.0 ng/mL with normal digital rectal examination
(DRE) and normal transrectal ultrasound (TRUS) are
required. Additional pre-operative criteria include sexually
154 J. Huang et al.potent before surgery and suitable for orthotropic
neobladder.
With the purpose of preservation of sexual function,
rectal function, and improving urinary continence in patients
with or thotopic bladder substitutes, we should attempt to
perform at least one side nerve-sparing cystectomy [28].
Unilateral nerve-sparing should be considered on the non-
tumor-bearing side. Bilateral nerve-sparing may be consid-
ered in patients with high risk non-muscle invasive disease or
invasive tumors at anterior wall or dome of the bladder [28].
4. Conclusion
Nerve-sparing RC is beneficial for both preservation of
sexual function and urinary continence according to current
studies. Nerve-sparing LRC and RARC may be an optimal
treatment choice in well-selected younger patients with
low-volume, organ-confined disease. We should attempt to
do, whenever possible, a nerve-sparing cystectomy at least
on one side. However, due to the need of a well-refined
surgical technique, nerve-sparing LRC and RARC is now
being performed only by experienced urological surgeons.
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